ATE423218T1 - Komponenten des ampk-wegs - Google Patents

Komponenten des ampk-wegs

Info

Publication number
ATE423218T1
ATE423218T1 AT03812515T AT03812515T ATE423218T1 AT E423218 T1 ATE423218 T1 AT E423218T1 AT 03812515 T AT03812515 T AT 03812515T AT 03812515 T AT03812515 T AT 03812515T AT E423218 T1 ATE423218 T1 AT E423218T1
Authority
AT
Austria
Prior art keywords
ampk
alter
activity
path
components
Prior art date
Application number
AT03812515T
Other languages
English (en)
Inventor
Javier Apfeld
Greg O'connor
Original Assignee
Elixir Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elixir Pharmaceuticals Inc filed Critical Elixir Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE423218T1 publication Critical patent/ATE423218T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Road Signs Or Road Markings (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Saccharide Compounds (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
AT03812515T 2002-12-04 2003-12-04 Komponenten des ampk-wegs ATE423218T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43080402P 2002-12-04 2002-12-04
US48826103P 2003-07-18 2003-07-18

Publications (1)

Publication Number Publication Date
ATE423218T1 true ATE423218T1 (de) 2009-03-15

Family

ID=32474596

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03812515T ATE423218T1 (de) 2002-12-04 2003-12-04 Komponenten des ampk-wegs

Country Status (6)

Country Link
EP (1) EP1576180B1 (de)
AT (1) ATE423218T1 (de)
AU (1) AU2003300818A1 (de)
CA (1) CA2508236A1 (de)
DE (1) DE60326272D1 (de)
WO (1) WO2004050898A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007044622A1 (en) 2005-10-07 2007-04-19 Yale University Use of mif and mif pathway agonists
US20090042810A1 (en) * 2007-04-27 2009-02-12 Genexel-Sein, Inc. AMPK Deficient Animals, Screening Methods, And Related Therapeutics And Diagnostics
GB0715284D0 (en) * 2007-08-06 2007-09-12 Medical Res Council Crystal structure of ampk and uses thereof
US9817001B2 (en) 2008-05-27 2017-11-14 Boston Heart Diagnostics Corporation Methods for determining LDL cholesterol treatment
WO2010005303A2 (en) * 2008-07-07 2010-01-14 Publiekrechtelijke Rechtspersoon Academisch Ziekenhuis Leiden H.O.D.N. Leids Universitair Medisch Centrum New indicators of human longevity and biological ageing rate
US8470541B1 (en) 2008-09-27 2013-06-25 Boston Heart Diagnostics Corporation Methods for separation and immuno-detection of biomolecules, and apparatus related thereto
US20120172413A1 (en) * 2009-06-26 2012-07-05 The Salk Institute For Biological Studies Increasing lifespan by modulating crtc expression or localization, and methods of screening for modulators of same
US8765377B2 (en) 2011-10-13 2014-07-01 Boston Heart Diagnostics Corporation Compositions and methods for treating and preventing coronary heart disease
WO2014180908A1 (en) * 2013-05-08 2014-11-13 Deutsches Krebsforschungszentrum Acip/peptide-based inhibition of cancer cachexia
US9828624B2 (en) 2013-07-24 2017-11-28 Boston Heart Diagnostics Corporation Driving patient compliance with therapy
US9739790B2 (en) 2014-11-17 2017-08-22 Boston Heart Diagnostic Corporation Cardiovascular disease risk assessment
WO2020214936A1 (en) * 2019-04-17 2020-10-22 University Of Houston System Methods of improving the longevity of immune cells
CN115261355B (zh) * 2022-09-14 2023-07-28 广东医科大学 AMPKα1琥珀酰化修饰及应用

Also Published As

Publication number Publication date
CA2508236A1 (en) 2004-06-17
WO2004050898A3 (en) 2005-11-10
DE60326272D1 (de) 2009-04-02
EP1576180B1 (de) 2009-02-18
AU2003300818A1 (en) 2004-06-23
WO2004050898A2 (en) 2004-06-17
EP1576180A4 (de) 2006-08-02
EP1576180A2 (de) 2005-09-21

Similar Documents

Publication Publication Date Title
ATE423218T1 (de) Komponenten des ampk-wegs
SG170813A1 (en) New compounds
MX2010002712A (es) Compuestos que modulan calcio intracelular.
SV2009003235A (es) Triazoles biciclicos como moduladores de la proteina cinasa ref. x-18476m
NO20084792L (no) Substituerte imidazol-4-karboksamider som kolecystokinin-1-reseptormodulatorer
BRPI0517015A (pt) compostos e composições como inibidores de atividade de receptor 1 de canabinóide
CL2011000478A1 (es) Compuestos derivados de 2-imidazol-propanamida sustituidos, activadores de glucoquinasa; composicion farmaceutica, util para tratar o retrasar la progresion o aparacion de la diabetes tipo ii o trastornos relacionados con la diabetes.
CY1108988T1 (el) Διαμορφωτες υποδοχεα βιταμινης d
CY1109341T1 (el) Διαμορφωτες υποδοχεα βιταμινης d τυπου φαινυλο-θειοφαινιου
BRPI0607307A2 (pt) compostos e composições como inibidores de proteìna cinase
SI1753512T1 (sl) Tetrahidropiridotiofeni
EA201001329A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
ATE538084T1 (de) Bicyclische 1,4-retigabin-analoga als kaliumkanalhemmer
ECSP055985A (es) Derivados de ácido 3-metil-2-(3-(2-fenil-oxazol-4-ilmetoxi)-ciclohexanocarbonil-aminobutírico y compuestos relacionados como moduladores de ppar para el tratamiento de diabetes de tipo 2 y aterosclerosis
ATE473004T1 (de) Substituierte imidazol-4-carboxamide als cholecystokinin-1-rezeptor-modulatoren
DE602007008868D1 (de) Substituierte imidazol-4-carboxamide als cholecystokinin-1-rezeptor-modulatoren
UA108073C2 (ru) 2,5-дизамещенные арилсульфонамидные антагонисты ccr3
ATE527379T1 (de) Modulation einer hsv-infektion
BRPI0606621A2 (pt) gene e proteìna de percepção de açucar regulados por nitrogênio e modulação dos mesmos
ATE489628T1 (de) Galk1s als modifikatoren des pten/akt-wegs
ATE536549T1 (de) Galnts als modifikatoren des igfr-weges und verwendungsverfahren
DE602005025737D1 (de) C20orf23 als modifikator des igfr-wegs und verwendungsverfahren
DE602008003411D1 (de) Verwendung von d-ribose zur behandlung von vorhofflimmern
WO2006031930A3 (en) Modulation of xbp-1 activity for treatment of metabolic disorders
DE602004027387D1 (de) Prkcs als modifikatoren des beta catenin pfads und anwendungsverfahren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties